Imagerie et cognition
Free Access
Issue
Med Sci (Paris)
Volume 27, Number 2, Février 2011
Imagerie et cognition
Page(s) 193 - 198
Section M/S revues
DOI https://doi.org/10.1051/medsci/2011272193
Published online 08 March 2011
  1. Helmer C, Pasquier F, Dartigues J. Épidémiologie de la maladie d’Alzheimer et des syndromes apparentés. Med Sci (Paris) 2006 ; 22 : 288-296. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Smith CD. Neuroimaging through the course of Alzheimer’s disease. J Alzheimers Dis 2010 ; 19 : 273-290. [PubMed] [Google Scholar]
  3. Chételat G, Desgranges B, Eustache F. Brain profile of hypometabolism in early Alzheimer’s disease: relationships with cognitive deficits and atrophy. Rev Neurol (Paris) 2006 ; 162 : 945-951. [PubMed] [Google Scholar]
  4. Lehéricy S, Marjanska M, Mesrob L, et al. Magnetic resonance imaging of Alzheimer’s disease. Eur Radiol 2007 ; 17 : 347-362. [CrossRef] [PubMed] [Google Scholar]
  5. Chételat G, Baron J. Early diagnosis of Alzheimer’s disease: contribution of structural neuroimaging. Neuroimage 2003 ; 18 : 525-541. [CrossRef] [PubMed] [Google Scholar]
  6. Fouquet M, Villain N, Chételat G, et al. Cerebral imaging and physiopathology of Alzheimer’s disease. Psychol Neuropsychiatr Vieil 2007 ; 5 : 269-279. [PubMed] [Google Scholar]
  7. Catheline G, Periot O, Amirault M, et al. Distinctive alterations of the cingulum bundle during aging and Alzheimer’s disease. Neurobiol Aging 2010 ; 31 : 1582-1592. [CrossRef] [PubMed] [Google Scholar]
  8. Sperling RA, Dickerson BC, Pihlajamaki M, et al. Functional alterations in memory networks in early Alzheimer’s disease. Neuromolecular Med 2010 ; 12 : 27-43. [CrossRef] [PubMed] [Google Scholar]
  9. Rowe CC, Ng S, Ackermann U, et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007 ; 68 : 1718-1725. [CrossRef] [PubMed] [Google Scholar]
  10. Villemagne VL, Fodero-Tavoletti MT, Pike KE, et al. The ART of loss: Abeta imaging in the evaluation of Alzheimer’s disease and other dementias. Mol Neurobiol 2008 ; 38 : 1-15. [CrossRef] [PubMed] [Google Scholar]
  11. Querbes O, Aubry F, Pariente J, et al. Early diagnosis of Alzheimer’s disease using cortical thickness: impact of cognitive reserve. Brain 2009 ; 132 : 2036-2047. [CrossRef] [PubMed] [Google Scholar]
  12. Chételat G, Fouquet M, Kalpouzos G, et al. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry. Neuropsychologia 2008 ; 46 : 1721-1731. [CrossRef] [PubMed] [Google Scholar]
  13. La Joie R, Fouquet M, Mézenge F, et al. Differential effect of age on hippocampal subfields assessed using a new high-resolution 3T MR sequence. Neuroimage 2010 ; 53 : 506-514. [CrossRef] [PubMed] [Google Scholar]
  14. Gerardin E, Chételat G, Chupin M, et al. Multidimensional classification of hippocampal shape features discriminates Alzheimer’s disease and mild cognitive impairment from normal aging. Neuroimage 2009 ; 47 : 1476-1486. [CrossRef] [PubMed] [Google Scholar]
  15. Chételat G, Desgranges B, de la Sayette V, et al. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 2003 ; 60 : 1374-1377. [PubMed] [Google Scholar]
  16. Chételat G, Eustache F, Viader F, et al. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase 2005 ; 11 : 14-25. [CrossRef] [PubMed] [Google Scholar]
  17. Jack CR, Shiung MM, Gunter JL, et al.. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004 ; 62 : 591-600. [PubMed] [Google Scholar]
  18. Fox NC, Schott JM. Imaging cerebral atrophy: normal ageing to Alzheimer’s disease. Lancet 2004 ; 363 : 392-394. [CrossRef] [PubMed] [Google Scholar]
  19. Chételat G, Landeau B, Eustache F, et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005 ; 27 : 934-946. [CrossRef] [PubMed] [Google Scholar]
  20. Fouquet M, Desgranges B, Landeau B, et al. Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer’s disease. Brain 2009 ; 132 : 2058-2067. [CrossRef] [PubMed] [Google Scholar]
  21. Mevel K, Desgranges B, Baron J, et al. Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches. Neuroimage 2007 ; 37 : 18-25. [CrossRef] [PubMed] [Google Scholar]
  22. Chételat G, Desgranges B, Landeau B, et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer’s disease. Brain 2008 ; 131 : 60-71. [CrossRef] [PubMed] [Google Scholar]
  23. Mevel K, Chetelat G, Desgranges B, et al. Alzheimer’s disease, hippocampus and neuroimaging. Encephale 2006 ; 32 : S1149-S1154. [PubMed] [Google Scholar]
  24. Vann SD, Aggleton JP, Maguire EA. What does the retrosplenial cortex do? Nat Rev Neurosci 2009 ; 10 : 792-802. [CrossRef] [PubMed] [Google Scholar]
  25. Villain N, Desgranges B, Viader F, et al. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer’s disease. J Neurosci 2008 ; 28 : 6174-6181. [CrossRef] [PubMed] [Google Scholar]
  26. Villain N, Fouquet M, Baron J, et al. Sequential relationships between gray matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer’s disease. Brain 2011 ; (sous presse). [Google Scholar]
  27. Seeley WW, Crawford RK, Zhou J, et al. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009 ; 62 : 42-52. [CrossRef] [PubMed] [Google Scholar]
  28. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002 ; 297 : 353-356. [CrossRef] [PubMed] [Google Scholar]
  29. Mormino EC, Kluth JT, Madison CM, et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009 ; 132 : 1310-1323. [CrossRef] [PubMed] [Google Scholar]
  30. Chételat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 2010 ; 67 : 317-324. [PubMed] [Google Scholar]
  31. Coatrieux JL, Velut J, Dillenseger JL, Toumoulin C. De l’imagerie médicale à la thérapie guidée par l’image. Med Sci (Paris) 2010 ; 26 : 1103-1109. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  32. Epelbaum J. Une liaison intraneuronale de peptide bêta-amyloïde et de protéine Tau solubles pour résoudre la question insoluble de la cause première de la maladie d’Alzheimer. Med Sci (Paris) 2006 ; 22 : 462-463. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.